SCHEMBL10153495

SCHEMBL10153495

c1cc2c(cn1)c1cc(-c3cc4c5cnccc5n5c6ccncc6c(c3)c45)cc3c4cnccc4n2c13

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 5/20 0.39
MAOB P27338 5/20 0.39
ACHE P22303 1/20 0.39
NFATC1 O95644 2/20 0.33
GSK3B P49841 2/20 0.33
DYRK1A Q13627 2/20 0.33
CYP2D6 P10635 1/20 0.33
MAPK10 P53779 3/20 0.33
ALDH1A1 P00352 1/20 0.33
ELANE P08246 1/20 0.31
CDC7 O00311 1/20 0.31
CDK2 P24941 1/20 0.31
TOP2A P11388 1/20 0.31
CCNT1 O60563 1/20 0.31
PIM1 P11309 1/20 0.31
CDK9 P50750 1/20 0.31
HASPIN Q8TF76 1/20 0.31
ATM Q13315 1/20 0.31
TNF P01375 1/20 0.31
KDM4E B2RXH2 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10153586 0.85 ACHE (0.42) MAOAMAOBACHECYP2D6ELANE
SCHEMBL24527871 0.84 DYRK1A (0.40) MAOAMAOBACHENFATC1GSK3B
SCHEMBL10153537 0.83 MAOA (0.40) MAOAMAOBACHECYP2D6MAPK10
SCHEMBL21889254 0.79 MAOA (0.42) MAOAMAOBACHECYP2D6ALDH1A1
SCHEMBL17265055 0.78 KDM4E (0.44) MAOAMAOBACHEDYRK1ACYP2D6
SCHEMBL10153562 0.78 MAOA (0.49) MAOAMAOBACHECYP2D6ELANE
SCHEMBL10153898 0.78 MAOA (0.39) MAOAMAOBACHECYP2D6MAPK10
SCHEMBL10153433 0.78 MAOA (0.39) MAOAMAOBACHECYP2D6MAPK10
SCHEMBL16656735 0.77 MAOA (0.56) MAOAMAOBACHECYP2D6ALDH1A1
SCHEMBL24527760 0.77 CYP19A1 (0.41) NFATC1GSK3BDYRK1AMAPK10ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8421066-B2 Organic electroluminescence device UDC IRELAND LIMITED (IE) 2013-04-16 US disclosed
US-8421066-B2 Organic electroluminescence device UDC IRELAND LIMITED (IE) 2013-04-16 US disclosed
US-20120178928-A1 ORGANIC ELECTROLUMINESCENCE DEVICE FUJIFILM CORPORATION (JP) 2012-07-12 US disclosed
US-20120178928-A1 ORGANIC ELECTROLUMINESCENCE DEVICE FUJIFILM CORPORATION (JP) 2012-07-12 US disclosed
US-8174002-B2 Organic electroluminescence device FUJIFILM CORPORATION (JP) 2012-05-08 US disclosed
US-8174002-B2 Organic electroluminescence device FUJIFILM CORPORATION (JP) 2012-05-08 US disclosed
US-20100051928-A1 ORGANIC ELECTROLUMINESCENCE DEVICE FUJIFILM CORPORATION (JP) 2010-03-04 US disclosed
US-20100051928-A1 ORGANIC ELECTROLUMINESCENCE DEVICE FUJIFILM CORPORATION (JP) 2010-03-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100051928-A1 ORGANIC ELECTROLUMINESCENCE DEVICE L1CAM, CHRM1, LEF1 MAOA 1485/4885MAOB 1553/4885ACHE 1356/4885
US-20120178928-A1 ORGANIC ELECTROLUMINESCENCE DEVICE L1CAM, CHRM1, LEF1 MAOA 1485/4885MAOB 1553/4885ACHE 1356/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.